Casdin Capital Portfolio

Casdin Capital 13F filer (CIK 0001534261).

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2020 · 45 positions · Total reported value $2.23B · Top-10 concentration 63.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 26.1% · 6 new · 3 cut · 3 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +47.2% · vs SPY +32.4% · Prev Value $1.32B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2020 13F filing, Casdin Capital disclosed 45 equity positions with a combined reported value of $2.23B. The filing implies a focused portfolio: its ten largest positions account for 63.1% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2020 were NVTAQ ($391.62M), BLFS ($169.01M), RLAY ($162.22M). By sector, the heaviest allocations are Health Care 53.8%, Industrials 4.1%. Versus the prior quarter, allocation shifted toward Health Care (+3.6pp), Industrials (+0.9pp) and away from Other (-4.5pp).

Versus the prior quarter, Casdin Capital opened 6 new positions, trimmed 3 and fully exited 3, a turnover rate of 26.1% of positions. The portfolio's overlap with the prior quarter was 81% of names.

The largest new positions opened in Q3 2020 were RLAY ($162.22M), PACB ($44.41M), TSHA ($18.38M).

Of the 3 positions fully exited versus the prior quarter, the largest were GRTSQ ($12.29M), VYGR ($9.46M), ZYME ($4.69M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2020)

  • RLAY RELAY THERAPEUTICS INC · $162.22M
  • PACB PACIFIC BIOSCIENCES CALIF IN · $44.41M
  • TSHA TAYSHA GENE THERAPIES IN · $18.38M
  • CELL PHENOMEX INC · $15.27M
  • IOVA IOVANCE BIOTHERAPEUTICS INC COM · $9.55M
  • DYN DYNE THERAPEUTICS INC · $7.47M

Fully Exited (vs previous quarter)

  • GRTSQ GRITSTONE BIO INC · prev qtr: $12.29M
  • VYGR VOYAGER THERAPEUTICS INC · prev qtr: $9.46M
  • ZYME ZYMEWORKS INC COM · prev qtr: $4.69M

Insider Transactions (Form 4)

Latest Casdin Capital buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Casdin Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 43 US equity positions with a combined value of $2.00B. HoldingsHub carries 43 quarters of its filings (Q4 2015–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-110894 (status: Approved), registered 2017-07-31
  • Regulatory AUM (Form ADV): $2.87B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 5 private funds, of which 2 hedge funds

Portfolio Structure

  • 43 positions · $2.00B reported value (Q2 2026)
  • Top 10 holdings = 77.4% of reported value
  • Largest position: RVMD (REVOLUTION MEDICINES INC) at 24.2%
  • Average position size: $46.46M

Sector Tilt

  • Health Care 94.2%
  • Industrials 5.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 6 new, 9 added, 3 reduced, 3 exited
  • 25 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 53.8%
Other 42.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.03M $391.62M 17.54%
17.54%
Hold
2 5.84M $169.01M 7.57%
7.57%
Add
3 3.81M $162.22M 7.26%
7.26%
New
4 1.55M $143.69M 6.43%
6.43%
Hold
5 3.05M $121.91M 5.46%
5.46%
Hold
6 870.00K $118.61M 5.31%
5.31%
Hold
7 620.00K $90.27M 4.04%
4.04%
Add
8 1.00M $75.97M 3.40%
3.40%
Hold
9 530.00K $74.43M 3.33%
3.33%
Hold
10 1.75M $61.25M 2.74%
2.74%
Add
11 1.63M $56.88M 2.55%
2.55%
Add
12 1.61M $49.80M 2.23%
2.23%
Hold
13 915.00K $49.36M 2.21%
2.21%
Reduce
14 1.92M $48.21M 2.16%
2.16%
Add
15 1.31M $46.94M 2.10%
2.10%
Hold
16 3.98M $46.78M 2.10%
2.10%
Reduce
17 1.19M $45.27M 2.03%
2.03%
Hold
18 4.50M $44.41M 1.99%
1.99%
New
19 150.00K $42.97M 1.92%
1.92%
Hold
20 945.00K $35.64M 1.60%
1.60%
Add
21 713.12K $34.68M 1.55%
1.55%
Hold
22 2.75M $28.32M 1.27%
1.27%
Add
23 3.35M $22.75M 1.02%
1.02%
Hold
24 266.43K $22.28M 1.00%
1.00%
Hold
25 395.00K $21.78M 0.97%
0.97%
Add
26 7.39M $21.58M 0.97%
0.97%
Add
27 980.00K $19.86M 0.89%
0.89%
Hold
28 820.44K $18.38M 0.82%
0.82%
New
29 1.65M $17.38M 0.78%
0.78%
Add
30 1.43M $17.07M 0.76%
0.76%
Hold
31 190.00K $15.80M 0.71%
0.71%
Hold
32 200.00K $15.27M 0.68%
0.68%
New
33 6.25M $14.06M 0.63%
0.63%
Add
34 1.44M $11.43M 0.51%
0.51%
Hold
35 1.08M $10.21M 0.46%
0.46%
Reduce
36 290.00K $9.55M 0.43%
0.43%
New
37 30.00K $9.27M 0.41%
0.41%
Hold
38 289.39K $8.75M 0.39%
0.39%
Hold
39 1.87M $7.69M 0.34%
0.34%
Add
40 370.00K $7.47M 0.33%
0.33%
New
41 75.00K $6.55M 0.29%
0.29%
Hold
42 251.51K $6.29M 0.28%
0.28%
Hold
43 139.66K $4.31M 0.19%
0.19%
Add
44 120.00K $4.02M 0.18%
0.18%
Hold
45 65.00K $3.33M 0.15%
0.15%
Hold

FAQ

What did Casdin Capital buy in 2020-Q3?

In its 2020-Q3 13F filing, Casdin Capital reported 45 equity positions worth $2.23B in aggregate; its largest disclosed positions were NVTAQ ($391.62M), BLFS ($169.01M), RLAY ($162.22M).

How large is Casdin Capital's portfolio?

Casdin Capital reported $2.23B of long equity holdings across 45 positions as of 2020-Q3. Top-10 holdings account for 63.1% of reported value.

What is Casdin Capital's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/casdin/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →